These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 34103245)

  • 1. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
    Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
    J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
    Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
    Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
    Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
    Huang SH; Tsai WS; You JF; Hung HY; Yeh CY; Hsieh PS; Chiang SF; Lai CC; Chiang JM; Tang R; Chen JS
    Ann Surg Oncol; 2019 Jun; 26(6):1685-1694. PubMed ID: 30915591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
    Søreide K; Søreide JA; Kørner H
    World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T-CEA score: a useful prognostic indicator based on postoperative CEA and pathological T4 levels for patients with stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Yokoyama Y; Ohta R; Shinji S; Yonaga K; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Kanaka S; Taniai N; Yoshida H
    Surg Today; 2023 Aug; 53(8):890-898. PubMed ID: 36707435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
    Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
    Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
    Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy.
    Udagawa S; Osumi H; Kozuki R; Ooki A; Wakatsuki T; Kurihara N; Mukai T; Yamaguchi T; Akiyoshi T; Fukunaga Y; Yamaguchi K; Shinozaki E
    Surg Today; 2024 Jul; 54(7):692-701. PubMed ID: 38103076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
    Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
    JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
    BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.
    Pu H; Yang W; Liu M; Pang X; Chen Y; Xiong Q
    Sci Rep; 2024 Mar; 14(1):6889. PubMed ID: 38519578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative carcinoembryonic antigen and D-dimer concentrations in patients undergoing curative resection for colorectal cancer.
    Ojima Y; Harano M; Sumitani D; Yoshimitsu M; Okajima M
    Surg Today; 2021 Jul; 51(7):1108-1117. PubMed ID: 33386463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors associated with primary cancer in curatively resected stage IV colorectal cancer.
    Huh JW; Lee WY; Park YA; Cho YB; Yun SH; Kim HC; Chun HK
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):435-41. PubMed ID: 24414039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.
    Ma L; Li W; Liu N; Ding Z; Cai J; Zhang Y
    Updates Surg; 2022 Jun; 74(3):999-1009. PubMed ID: 35322387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
    Hermunen K; Soveri LM; Boisen MK; Mustonen HK; Dehlendorff C; Haglund CH; Johansen JS; Osterlund P
    Acta Oncol; 2020 Dec; 59(12):1416-1423. PubMed ID: 32790589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.